Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical Laboratory
|
June 15, 2022
Prevalence and Antimicrobial Resistance of Ureaplasma urealyticum and Mycoplasma hominis in Patients with Genital Tract Infection in Jiangsu, China
Ruixiang Luo, Kang Xun, Lingli Zuo, et al.
Journal of Medicinal Chemistry
|
June 27, 2025
LC-MF-4, a Novel FGFR3 Degrader for Therapeutic Intervention in FGFR3-Altered Cancers
Lulu Zheng, Jiaqi Cao, Lin Ma, et al.
Molecular Diversity
|
October 14, 2024
Anti-inflammatory effects of resveratrol in treating interstitial cystitis/bladder pain syndrome: a multi-faceted approach integrating network pharmacology, molecular docking, and experimental validation
Wenshuang Li, Ruixiang Luo, Zheng Liu, et al.
Polymers
|
March 14, 2026
Deformation Behavior and Accuracy Control in Gas-Assisted Diaphragm Forming of Composites Using Multi-Point Flexible Die
Deyu Yue, Ruixiang Luo, Yuan Li, et al.
Communications Biology
|
May 8, 2026
Targeting CCR1-mediated macrophage phenotypic switching to alleviate bladder pain and urinary dysfunction in interstitial cystitis
Ruixiang Luo, Wenshuang Li, Bolong Liu, et al.
European Journal of Medicinal Chemistry
|
May 17, 2025
Discovery of LC-SF-14, a selective dual inhibitor of SHP2 and FGFR for the treatment of FGFR2-driven gastric cancer
Lei Zheng, Yuhan Wang, Zheng Jiang, et al.
Journal of Medicinal Chemistry
|
May 23, 2023
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
Lin Ma, Yingying Li, Ruixiang Luo, et al.
EMBO Reports
|
August 22, 2022
eEF2 in the prefrontal cortex promotes excitatory synaptic transmission and social novelty behavior
Xuanyue Ma, Liuren Li, Ziming Li, et al.
Bioorganic Chemistry
|
February 23, 2024
Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury
Binhao Cai, Ying Xu, Ruixiang Luo, et al.
Journal of Medicinal Chemistry
|
May 9, 2024
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases
Lingfeng Chen, Ruixiang Luo, Lin Ma, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical Laboratory
|
June 15, 2022
Prevalence and Antimicrobial Resistance of Ureaplasma urealyticum and Mycoplasma hominis in Patients with Genital Tract Infection in Jiangsu, China
Ruixiang Luo, Kang Xun, Lingli Zuo, et al.
Journal of Medicinal Chemistry
|
June 27, 2025
LC-MF-4, a Novel FGFR3 Degrader for Therapeutic Intervention in FGFR3-Altered Cancers
Lulu Zheng, Jiaqi Cao, Lin Ma, et al.
Molecular Diversity
|
October 14, 2024
Anti-inflammatory effects of resveratrol in treating interstitial cystitis/bladder pain syndrome: a multi-faceted approach integrating network pharmacology, molecular docking, and experimental validation
Wenshuang Li, Ruixiang Luo, Zheng Liu, et al.
Polymers
|
March 14, 2026
Deformation Behavior and Accuracy Control in Gas-Assisted Diaphragm Forming of Composites Using Multi-Point Flexible Die
Deyu Yue, Ruixiang Luo, Yuan Li, et al.
Communications Biology
|
May 8, 2026
Targeting CCR1-mediated macrophage phenotypic switching to alleviate bladder pain and urinary dysfunction in interstitial cystitis
Ruixiang Luo, Wenshuang Li, Bolong Liu, et al.
European Journal of Medicinal Chemistry
|
May 17, 2025
Discovery of LC-SF-14, a selective dual inhibitor of SHP2 and FGFR for the treatment of FGFR2-driven gastric cancer
Lei Zheng, Yuhan Wang, Zheng Jiang, et al.
Journal of Medicinal Chemistry
|
May 23, 2023
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
Lin Ma, Yingying Li, Ruixiang Luo, et al.
EMBO Reports
|
August 22, 2022
eEF2 in the prefrontal cortex promotes excitatory synaptic transmission and social novelty behavior
Xuanyue Ma, Liuren Li, Ziming Li, et al.
Bioorganic Chemistry
|
February 23, 2024
Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury
Binhao Cai, Ying Xu, Ruixiang Luo, et al.
Journal of Medicinal Chemistry
|
May 9, 2024
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases
Lingfeng Chen, Ruixiang Luo, Lin Ma, et al.
Page
of 4